「head」の検索結果
27件：6～10件目を表示
もしかして
-
al Co., Ltd. Acquisition of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received appr...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
r "SJP-0049" for the treatment of Allergic Conjunctivitis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Shuhei Yoshida; hereinafter “Senju”) hereby announces that it...
https://www.senju.co.jp/system/files/content_news/2026-08/ENG_20260820.pdf -
r "SJP-0049" for the treatment of Allergic Conjunctivitis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Shuhei Yoshida; hereinafter “Senju”) hereby announces that it...
https://www.senju.co.jp/system/files/content_news/2026-08/ENG_20260820_0.pdf -
24 Senju Pharmaceutical Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
24 Senju Pharmaceutical Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf